An FDA-cleared, Medicare-covered programmable peripheral nerve stimulator for painful diabetic peripheral neuropathy. Fine electrodes are applied to the auricular branches at the ear, worn for about 20 days in most cases, and then taken out — nothing stays in permanently.
Why use nerve stimulation when neuropathy medication fails?
Painful diabetic peripheral neuropathy is one of the least satisfying conditions in medicine to treat. Nerve-pain medications help some people partially and sedate a good many of them. The pain frequently persists even when blood glucose is well controlled — which tells you the damage is not purely a sugar problem.
The reasoning behind this approach is that diabetic nerve damage involves impaired nerve blood supply and energy failure inside the nerve, not just glucose exposure. Stimulating specific cranial and upper cervical nerves is intended to act on the autonomic and inflammatory signaling upstream of that, rather than simply masking the pain signal at the end of it.
What does percutaneous nerve stimulation involve?
The system is a programmable peripheral electrical nerve stimulator — an FDA-cleared Class II device. It is applied to the auricular branches at the ear and acts as a vagal stimulator. Its FDA classification is product code GZF, “Stimulator, Peripheral Nerve, Implanted (Pain Relief),” at 21 CFR 882.5870. Placement is percutaneous, under local anesthetic, without an incision or a surgical pocket.
The targets are not the feet, which surprises most patients:
- The auricular branches of the vagus nerve, at the ear — the primary target
- Branches of the trigeminal nerve
- The upper cervical nerve roots, C1 to C3, and the trigeminocervical complex
Placement takes roughly half an hour. You go home the same day with a small external stimulator. Most patients wear the system for about 20 days; we go up to 30 where the response warrants it. Removal is a short office visit.
Because the stimulator is programmable, the output is set for you rather than fixed — and it can be adjusted during the wear period if the response or the comfort of the settings calls for it.
This is not the handheld device — and not a permanent implant
We offer two different vagus-nerve treatments and they are easy to confuse. Non-invasive VNS is a handheld device held against the neck, used for cluster headache and migraine. Nothing is placed at all.
This treatment is different. Electrodes genuinely go under the skin, so it is a procedure — but it is temporary by design. There is no generator implanted in the chest, no permanent hardware, and removal is a routine office visit rather than surgery.
It is also not a spinal cord stimulator. Nothing is placed near the spinal cord, and there is no trial-then-implant sequence.
What the evidence actually shows
The most substantial published work on this approach is Staats and colleagues, Frontiers in Neuroscience, August 2025. It is worth reading what it did and did not establish, because the headline numbers are striking.
What they found. In 83 patients with severe type 2 diabetes and painful neuropathy, stimulated for 19 days and followed for 90 days after removal: pain scores fell from 7.92 to 1.04 on a 0–10 scale, mean blood glucose fell from 209 to 121 mg/dL, and HbA1c fell from 8.9% to 5.8%.
What that is and is not. This was an analysis of patients treated in the routine course of care — not a randomized trial, and with no control group. All 83 were from a single Native American population, which limits how far the results generalize. Eight of the original 91 were lost to follow-up.
So the honest summary is: a large effect, in a real clinical population, without the study design that would let anyone call it proven. That is a reason to consider the treatment seriously and a reason not to promise you those numbers.
We will not quote you an expected pain score or an expected HbA1c. The published figures come from one uncontrolled series in one population. If we thought they were guaranteed we would say so, and they are not. What we will do is tell you honestly whether you fit the group in which it has been studied.
Who is a candidate for nerve stimulation for diabetic neuropathy?
- Painful diabetic peripheral neuropathy that has not responded adequately to nerve-pain medication
- People who cannot tolerate the sedation, dizziness or cognitive effects of those medications
- People who want to avoid a permanent implant
- People whose glucose is reasonably controlled and who still have burning, night-worse foot pain — the group medication tends to fail
It is not a substitute for metabolic treatment. We would run it alongside metabolic and glucose work, not instead of it, because the underlying driver still needs addressing.
What should I expect while wearing the stimulator?
- Placement under local anesthetic, roughly 30 minutes, and you go home afterwards.
- You wear a small external stimulator — typically about 20 days, up to 30. It is discreet under clothing.
- Site soreness for a few days is common; the electrodes themselves are not usually felt once settled.
- Removal is a short office visit — no surgery, no stitches to speak of.
- Any benefit is assessed in the weeks and months after removal rather than during the wear period.
What are the risks of percutaneous nerve stimulation?
Because the electrodes are placed through the skin, this carries a small risk of infection at the entry sites, bleeding, and local irritation or discomfort. Lead migration can occur. There is no implanted generator, so the risks associated with permanent hardware — device failure, revision surgery, long-term MRI restrictions — do not apply. Your specific risks, and how they interact with your diabetes and any blood thinner, are discussed before you consent.
To find out whether you fit, call or text us. We are at 12174 Natural Bridge Rd, Suite 110, St. Louis, MO 63044.
Common questions
Is this the same as a spinal cord stimulator?
No. Nothing is placed near the spinal cord, and there is no trial-then-implant sequence. The electrodes go through the skin at the ear, aimed at branches of the vagus and trigeminal nerves and the upper cervical nerve roots. There is no generator implanted in the chest and no permanent hardware, and the system comes out in a short office visit.
How long do you wear a nerve stimulator for diabetic neuropathy?
Most patients wear it for about 20 days, and we go up to 30 where the response warrants it. Placement takes roughly half an hour under local anesthetic, and you go home the same day with a small external stimulator that is discreet under clothing. Removal is a short office visit, with no surgery and no stitches to speak of.
Will I feel the electrodes?
Soreness at the entry sites for a few days is common. Once the electrodes settle, most patients do not usually feel them. Because the stimulator is programmable, the output is set for you rather than fixed, and it can be adjusted during the wear period if the response or the comfort of the settings calls for it.
Does nerve stimulation replace diabetes treatment?
No. It is not a substitute for metabolic treatment. We run it alongside metabolic and glucose work, not instead of it, because the underlying driver of the nerve damage still needs addressing. We would not have you change your diabetes management on the expectation of what the stimulator might do to your blood sugar.
When will I know if nerve stimulation worked?
Any benefit is assessed in the weeks and months after removal, not during the wear period. We will not quote you an expected pain score, because the published figures come from one uncontrolled series in one population. What we will tell you honestly, before you start, is whether you fit the group in which it has been studied.
Is this a permanent implant?
No. It is a temporary programmable peripheral nerve stimulator. The electrodes are placed through the skin, worn for about 20 days in most cases and up to 30, then removed in the office. There is no generator implanted and no permanent hardware.
Peripheral Nerve Stimulation (PNS) covers other stimulation systems that are worn for a set period and then removed.
Why stimulate my ear and neck for pain in my feet?
Because the approach targets the autonomic and inflammatory signaling thought to underlie diabetic nerve damage, rather than the painful nerves themselves. The vagus and trigeminal branches are reachable at the ear and face; the feet are not the target.
Vagus Nerve Stimulation (VNS) explains what the vagus nerve does.
Is it the same as the handheld vagus nerve device?
No. That one is non-invasive VNS for cluster headache and migraine, held against the neck with nothing placed. This is a temporary percutaneous system for diabetic neuropathy.
Will my blood sugar improve?
The published series reported substantial falls in glucose and HbA1c. That study had no control group, so we present it as promising rather than proven, and we would not have you change diabetes management on the expectation of it.
Metabolic and Lifestyle Care covers the glucose work we run alongside it.
What if it does not help?
The system comes out at the end of the wear period regardless. Nothing has been permanently committed, which is the main practical argument for trying it.
Does insurance cover it?
It is an FDA-cleared Class II device, and peripheral nerve stimulation is a covered category under Medicare nationally — NCD 160.7, Electrical Nerve Stimulators, which also addresses temporary stimulation used to assess whether continued treatment is suitable. Coverage still depends on meeting the policy criteria, and commercial plans vary, so we verify your specific plan before scheduling rather than after.
Insurance & Medicaid covers Medicare, MO HealthNet and commercial plans.
Sources
- Raghu ALB et al. Invasive Electrical Neuromodulation for the Treatment of Painful Diabetic Neuropathy: Systematic Review and Meta-Analysis. Neuromodulation : journal of the International Neuromodulation Society, 2021. PubMed 32588933
- Xu J et al. Peripheral Nerve Stimulation in Pain Management: A Systematic Review. Pain physician, 2021. PubMed 33740342
- D’Souza RS et al. Evidence-Based Treatment of Painful Diabetic Neuropathy: a Systematic Review. Current pain and headache reports, 2022. PubMed 35716275
- Strand N et al. Evidence-Based Clinical Guidelines from the American Society of Pain and Neuroscience for the Use of Implantable Peripheral Nerve Stimulation in the Treatment of Chronic Pain. Journal of pain research, 2022. PubMed 36039168
Hurt in an accident? Start here.
You do not need a lawyer, a police report or a referral to be seen. Bring your symptoms and we will work out the rest.
Monday–Friday, 8:00 a.m. – 4:00 p.m. Same-day appointments are often available for new accident and injury patients.